Sure, and I never said otherwise. But all things considered this is pretty minor.
>They've made the vaccine demonstrably less safe, either through carelessness or because they don't care. Don't minimize that, or assume it's the only place where the reality of sputnik doesn't match up to the phase 3 data.
Yes, this does make the vaccine marginally less safe. Not by much. Empirically, after millions of doses administered, the safety profile of the vaccine is more than acceptable as is.
>The fix is Gamaleya taking their current production facilities offline figure out where the problem is and fix it. Unless you're suggesting that regulators should just go full YOLO on this and let it slide, which is a stupid idea.
I literally say the exact same thing. In any case, Gamelaya right now is trying to get other people to produce the vaccines, but sure they should fix this issue. It will not be complicated.
You don't sell medicines to people which don't meet the specs you made public about them.
> The vaccine is going to work essentially identically to if it wasn't able to replicate. The difference is that you might get an adenovirus infection, which is basically a cold.
They've made the vaccine demonstrably less safe, either through carelessness or because they don't care. Don't minimize that, or assume it's the only place where the reality of sputnik doesn't match up to the phase 3 data.
> This should be a pretty easy fix, actually.
The fix is Gamaleya taking their current production facilities offline figure out where the problem is and fix it. Unless you're suggesting that regulators should just go full YOLO on this and let it slide, which is a stupid idea.